Meta-analysis of 12 RCTs (4765 women without preexisting diabetes): myo-inositol in pregnancy or preconception cut gestational diabetes risk by 44% vs placebo or standard care, with no significant differences in hypertensive disorders, caesarean or neonatal outcomes.
Meta-analysisn = 4,765
Poyatos-León et al. The effect of myo-inositol supplementation on gestational diabetes mellitus prevention: a systematic review and meta-analysis